Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS
· Delayed Price · Currency is USD
2.700
0.00 (0.00%)
Jun 6, 2025, 4:00 PM EDT
HNSPF Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 6, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Market Capitalization | 20,610 | 13,202 | 11,951 | 11,269 | 14,430 | 28,704 | Upgrade
|
| Market Cap Growth | 10.47% | 10.47% | 6.05% | -21.91% | -49.73% | 49.13% | Upgrade
|
| Enterprise Value | 17,450 | 9,968 | 9,325 | 8,742 | 12,233 | 26,321 | Upgrade
|
| Last Close Price | 2.70 | 2.13 | 1.83 | - | - | - | Upgrade
|
| PE Ratio | 34.41 | 22.04 | 25.86 | 30.08 | 33.79 | 72.95 | Upgrade
|
| PS Ratio | 12.27 | 7.86 | 8.39 | 8.28 | 9.23 | 21.56 | Upgrade
|
| PB Ratio | 5.25 | 3.36 | 3.29 | 3.43 | 4.58 | 10.48 | Upgrade
|
| P/TBV Ratio | 5.29 | 3.39 | 3.31 | 3.44 | 4.58 | 10.49 | Upgrade
|
| P/FCF Ratio | 41.32 | 26.47 | 29.25 | 31.49 | 43.30 | 194.63 | Upgrade
|
| P/OCF Ratio | 38.95 | 24.95 | 27.19 | 28.35 | 35.57 | 78.39 | Upgrade
|
| EV/Sales Ratio | 10.49 | 5.93 | 6.54 | 6.43 | 7.82 | 19.77 | Upgrade
|
| EV/EBITDA Ratio | 29.90 | 17.01 | 21.86 | 20.57 | 25.20 | 57.49 | Upgrade
|
| EV/EBIT Ratio | 32.98 | 18.65 | 24.68 | 23.13 | 27.55 | 61.97 | Upgrade
|
| EV/FCF Ratio | 34.99 | 19.99 | 22.83 | 24.43 | 36.71 | 178.47 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.17 | 0.19 | 0.19 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 1.41 | 1.48 | 1.24 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.03 | 0.03 | 1.49 | 1.77 | 1.81 | 0.10 | Upgrade
|
| Asset Turnover | 0.38 | 0.38 | 0.32 | 0.33 | 0.41 | 0.43 | Upgrade
|
| Inventory Turnover | 1.82 | 1.82 | 2.02 | 2.03 | 2.46 | 2.25 | Upgrade
|
| Quick Ratio | 9.90 | 9.90 | 4.11 | 9.64 | 7.50 | 6.30 | Upgrade
|
| Current Ratio | 10.18 | 10.18 | 4.21 | 9.86 | 7.67 | 6.43 | Upgrade
|
| Return on Equity (ROE) | 16.05% | 16.05% | 13.53% | 12.11% | 14.31% | 16.62% | Upgrade
|
| Return on Assets (ROA) | 7.54% | 7.54% | 5.31% | 5.70% | 7.35% | 8.59% | Upgrade
|
| Return on Capital (ROIC) | 8.28% | 8.28% | 5.86% | 6.41% | 8.43% | 11.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.50% | 13.50% | 10.20% | 9.50% | 11.70% | 15.30% | Upgrade
|
| Earnings Yield | 2.91% | 4.54% | 3.87% | 3.32% | 2.96% | 1.37% | Upgrade
|
| FCF Yield | 2.42% | 3.78% | 3.42% | 3.18% | 2.31% | 0.51% | Upgrade
|
| Dividend Yield | - | 2.03% | 1.49% | - | - | - | Upgrade
|
| Payout Ratio | 42.51% | 42.51% | 19.90% | 27.56% | 14.04% | 163.49% | Upgrade
|
| Buyback Yield / Dilution | 1.16% | 1.16% | -1.52% | 1.14% | -2.04% | -7.31% | Upgrade
|
| Total Shareholder Return | - | 3.19% | -0.03% | 1.14% | -2.04% | -7.31% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.